Furthermore, the prognostic analysis of these genes in MT1-deletion and non-deletion cases were performed and TTK, BUB1, NR1I2, and CYP8B1 may be the potential biomarkers for HCC with MT1-deletion. The gene discussed is MT1X; the disease is hepatocellular carcinoma.